- Home
- BEAT vs RPTX Comparison
BEAT vs RPTX Comparison
Compare BEAT & RPTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BEAT | RPTX |
|---|---|---|
| Founded | 2015 | 2016 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Retail: Computer Software & Peripheral Equipment | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 82.7M | 92.4M |
| IPO Year | 2021 | 2020 |
Fundamental Metrics
Financial Performance| Metric | BEAT | RPTX |
|---|---|---|
| Price | $2.07 | $2.56 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 1 |
| Target Price | ★ $6.75 | $3.00 |
| AVG Volume (30 Days) | ★ 2.8M | 1.5M |
| Earning Date | 11-13-2025 | 03-02-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $11,870,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $3,233.33 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.54 | $0.89 |
| 52 Week High | $4.00 | $2.66 |
Technical Indicators
Market Signals| Indicator | BEAT | RPTX |
|---|---|---|
| Relative Strength Index (RSI) | 45.75 | 65.65 |
| Support Level | $2.23 | $2.52 |
| Resistance Level | $2.60 | $2.61 |
| Average True Range (ATR) | 0.24 | 0.04 |
| MACD | -0.09 | -0.01 |
| Stochastic Oscillator | 2.45 | 29.63 |
Price Performance
Historical ComparisonAbout BEAT Heartbeam Inc.
HeartBeam Inc is a medical technology company is focusing on developing and commercializing higher resolution ambulatory Electrocardiogram ("ECG") solutions that enable the detection and monitoring of cardiac disease outside a healthcare facility setting. The Company's ability to develop higher-resolution ECG solutions is achieved through the development of the Company's proprietary and patented Vector Electrocardiography ("VECG") technology platform. The Company has validated this technology and is seeking U.S. Food and Drug Administration ("FDA") clearance for its initial telehealth products.
About RPTX Repare Therapeutics Inc.
Repare Therapeutics Inc is a precision medicine oncology company focused on the development of synthetic lethality-based therapies for patients with cancer. The Company's focus is the research, development and commercialization of precision oncology drugs targeting specific vulnerabilities of tumors in genetically defined patient populations.